PL413596A1 - New compounds derivatives of usnic acid, method for producing them, pharmaceutical composition and application - Google Patents
New compounds derivatives of usnic acid, method for producing them, pharmaceutical composition and applicationInfo
- Publication number
- PL413596A1 PL413596A1 PL413596A PL41359615A PL413596A1 PL 413596 A1 PL413596 A1 PL 413596A1 PL 413596 A PL413596 A PL 413596A PL 41359615 A PL41359615 A PL 41359615A PL 413596 A1 PL413596 A1 PL 413596A1
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical composition
- application
- new compounds
- producing
- usnic acid
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- -1 compounds derivatives of usnic acid Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 229940126062 Compound A Drugs 0.000 abstract 2
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010008342 Cervix carcinoma Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010060862 Prostate cancer Diseases 0.000 abstract 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010881 cervical cancer Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Przedmiotem zgłoszenia są nowe związki A i B, gdzie w pozycji 9b grupa CH3 jest w różnych pozycjach przestrzennych. Związek A to mieszanina racemiczna, a związek B to enancjomer S. Ponadto ujawniono sposób otrzymywania związków A i B, kompozycję farmaceutyczną zawierającą, związek A i/lub B oraz zastosowanie związków A i/lub B do wytwarzania środka leczniczego do zapobiegania i/lub leczenia raka, w szczególności raka piersi, raka szyjki macicy, raka prostaty.The subject of the application are new compounds A and B, where in position 9b the CH3 group is in different spatial positions. Compound A is a racemic mixture and compound B is an S enantiomer. Furthermore, a method for preparing compounds A and B, a pharmaceutical composition comprising, compound A and / or B and the use of compounds A and / or B in the manufacture of a medicament for the prevention and / or treatment are disclosed cancer, in particular breast cancer, cervical cancer, prostate cancer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL413596A PL233080B1 (en) | 2015-08-19 | 2015-08-19 | New compounds derivatives of usnic acid, method for producing them, pharmaceutical composition and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL413596A PL233080B1 (en) | 2015-08-19 | 2015-08-19 | New compounds derivatives of usnic acid, method for producing them, pharmaceutical composition and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL413596A1 true PL413596A1 (en) | 2017-02-27 |
| PL233080B1 PL233080B1 (en) | 2019-08-30 |
Family
ID=58092011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL413596A PL233080B1 (en) | 2015-08-19 | 2015-08-19 | New compounds derivatives of usnic acid, method for producing them, pharmaceutical composition and application |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL233080B1 (en) |
-
2015
- 2015-08-19 PL PL413596A patent/PL233080B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL233080B1 (en) | 2019-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201600204A1 (en) | HINAZOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITION ON THEIR BASIS AND THEIR APPLICATION FOR THE PREVENTION OR TREATMENT OF THE TUMOR | |
| MX391180B (en) | Pyrazolo-heteroaryl derivative, preparation method and medical use thereof | |
| GEAP201914678A (en) | New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| PH12018500097A1 (en) | Combination of pd-1 antagonist with an egfr inhibitor | |
| MY196909A (en) | Boronic acid derivatives and therapeutic uses thereof | |
| EA201892395A1 (en) | DRUG COMPOSITIONS OF LSD1 INHIBITOR | |
| GEAP201914679A (en) | New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| BR112015023948A2 (en) | compound of formula (i), pharmaceutical composition, method for treating and / or preventing a proliferative disease and for inhibiting or differentiating growth of a cancer stem cell | |
| EA201592250A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of diseases | |
| MX2015012414A (en) | Salt of omecamtiv mecarbil and process for preparing salt. | |
| MD20140073A2 (en) | New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them | |
| EA201691918A1 (en) | PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | |
| EA201590520A1 (en) | PHARMACEUTICAL COMPOSITION WITH COATING CONTAINING REGORAPHENIB | |
| MX377202B (en) | DERIVATIVE BASED ON 1,2-NAPHTHOQUINONE AND METHOD OF PREPARATION THEREOF. | |
| MX2016001980A (en) | Compounds and compositions as inhibitors of mek. | |
| MD20160016A2 (en) | New indolizine compounds, process for making them and pharmaceutical compositions containing them | |
| MX2015016425A (en) | Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease. | |
| MX383254B (en) | COMBINATION COMPRISING A GLUCOCORTICOID AND EDO-S101. | |
| MX2020001875A (en) | Polymorphic form of tg02. | |
| PH12016502353A1 (en) | Pharmaceutical composition | |
| BR112015031417A8 (en) | pharmaceutical dosage form, pharmaceutical composition, methods for treating a patient in need of cysteamine and for preparing a dosage form | |
| GEP20207108B (en) | Substituted 2,4 diamino-quinoline as new anticancer agents | |
| MX2016003522A (en) | Quinazoline derivatives and their use as dna methyltransferase inhibitors. | |
| MX376029B (en) | Isoindole compounds | |
| MX2020006434A (en) | Novel mtor inhibitor compounds. |